Headquarters
France
team size
-
founded
-
website
http://anagenesis-biotech.com
funding probability score
total disclosed funding
last round valuation estimate
disclosed funding rounds
latest round
latest funding stage
next round estimate
development stage
number of investors
number of competitors
monthly web visits
twitter followers
Offices
France
HQ address
650 Boulevard Gonthier d’Andernach, Illkirch-graffenstaden, 67400, FRA
Email
contact@anagenesis-biotech.com
description
Anagenesis Biotechnologies is a preclinical‐stage stem cell-based company focused on developing novel treatments for genetic and age-related muscle degenerative diseases with unmet medical needs.

Anagenesis Biotechnologies secured two private investments from the AFM (French muscular dystrophy association) to develop applications in the skeletal muscle therapeutic area and from Cap Innov'Est. Anagenesis Biotechnologies aim is to become the world leader in muscle-related diseases.

There is much more to this profile.
Log in or sign up for free to see the whole thing.

Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats